Publication | Closed Access

A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a gynecologic oncology group study

MedicineGynecologyPhase Ii StudyPeritoneal CarcinomaCancer TreatmentOncologyRadiation OncologyGynecology OncologyEndocrine-related CancerOvarian Cancer